Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-07ABEO3Power of Attorney for Keith A. GoldanMEDIUM
This filing details a Power of Attorney granted by Keith A. Goldan to Joseph W. Vazzano (Chief Financial Officer) and Brendan M. O'Malley (Chief Legal Officer) of Abeona Therapeutics Inc. The attorneys-in-fact are authorized to act on Mr. Goldan's behalf for all necessary actions related to SEC filings, including EDGAR...
Micro CapBiotechnology
2026-04-07ALNY3ALNYLAM PHARMACEUTICALS, INC. - Form 3 FilingMEDIUM
This filing details the initial ownership of securities by Melissa McLaughlin, Chief Human Resources Officer of ALNYLAM PHARMACEUTICALS, INC. As of March 25, 2026, McLaughlin directly holds 13,353 shares of common stock. This includes 11,730 shares from restricted stock units (RSUs) granted on April 1, 2025, and 1,623 ...
Mega CapBiotechnology
2026-04-07CASI3CASI Pharmaceuticals Officer Stock Option Holdings ReportMEDIUM
This Form 3 filing reports the initial beneficial ownership of CASI Pharmaceuticals, Inc. (CASIF) securities by Hai Huang, the company's Global Chief Commercial Officer. The filing details Huang's stock option holdings totaling 270,000 ordinary shares across multiple option grants with different exercise prices and ves...
Nano CapBiotechnology